Cargando…
Engineered clustered myoblast cell injection augments angiogenesis and muscle regeneration in peripheral artery disease
The low survival rate of administered cells due to ischemic and inflammatory environments limits the efficacy of the current regenerative cell therapy in peripheral artery disease (PAD). This study aimed to develop a new method to enhance the efficacy of cell therapy in PAD using cell sheet technolo...
Autores principales: | Miyake, Keisuke, Miyagawa, Shigeru, Harada, Akima, Sawa, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899600/ https://www.ncbi.nlm.nih.gov/pubmed/35007760 http://dx.doi.org/10.1016/j.ymthe.2022.01.008 |
Ejemplares similares
-
Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia
por: Nakagawa, Takaya, et al.
Publicado: (2020) -
Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model
por: Iseoka, Hiroko, et al.
Publicado: (2020) -
Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy
por: Ohkawara, Hirotatsu, et al.
Publicado: (2018) -
Autologous skeletal myoblast patch implantation prevents the deterioration of myocardial ischemia and right heart dysfunction in a pressure-overloaded right heart porcine model
por: Araki, Kanta, et al.
Publicado: (2021) -
Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT
por: Masada, Kenta, et al.
Publicado: (2020)